LisaBarroilhetMD
Obstetrics & Gynecology • Madison, WIGynecologic Oncology
Clinical Fellow in Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital
Dr. Barroilhet is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-265-1700Fax+1 608-263-2201
Education & Training
Brigham and Women’s HospitalFellowship, Gynecologic Oncology, 2012
University of North Carolina HospitalsResidency, Obstetrics and Gynecology, 2005 - 2009
University of Minnesota Medical SchoolClass of 2005
Certifications & Licensure
IL State Medical License 2016 - 2026
WI State Medical License 2012 - 2025
MA State Medical License 2009 - 2012
NC State Medical License 2005 - 2009- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA Start of enrollment: 2014 Sep 01
- Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2014 Jul 21
- Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients Start of enrollment: 2019 Jul 29
Publications & Presentations
PubMed
- 10 citationsA randomized phase II evaluation of weekly gemcitabine plus pazopanib versus weekly gemcitabine alone in the treatment of persistent or recurrent epithelial ovarian, f...Linda R. Duska, Gina R. Petroni, Nikole Varhegyi, Jubilee Brown, Danijela Jelovac
Gynecologic Oncology. 2020-06-01 - 353 citationsOvarian cancer, version 2.2020Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum-Gamez, Lisa Barroilhet, Kian Behbakht
Journal of the National Comprehensive Cancer Network. 2021-02-02 - 120 citationsBerzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial.Panagiotis A. Konstantinopoulos, Su Chun Cheng, Andrea E. Wahner Hendrickson, Richard T. Penson, Susan Schumer
The Lancet. Oncology. 2020-06-15
Journal Articles
- Neoadjuvant Chemotherapy Is Associated with a High Rate of Perioperative Blood Transfusion at the Time of Interval Cytoreductive SurgeryJoseph Connor, Erin E Medlin, Brock Polnaszek, Lisa Barroilhet, BioMed Central
Press Mentions
BRCA: What It Means to Be at Higher Risk for CancerAugust 19th, 2019
Women Shouldn’t Have to Resort to Second-Rate Options for Comprehensive HealthcareApril 17th, 2018
Local Doctor, Patient Discourage Use of Newly-Approved 23andMe Cancer Risk TestApril 3rd, 2018- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
